Phibro Animal Health (NASDAQ:PAHC) updated its FY19 earnings guidance on Tuesday. The company provided earnings per share guidance of $1.68-1.72 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.75. Phibro Animal Health also updated its FY 2019 guidance to $1.68-1.72 EPS.
A number of equities analysts recently weighed in on the stock. BidaskClub raised shares of Phibro Animal Health from a hold rating to a buy rating in a research report on Wednesday, August 8th. Morgan Stanley increased their price objective on shares of Phibro Animal Health from $36.00 to $46.00 and gave the stock an underweight rating in a research report on Wednesday, August 29th. Finally, Zacks Investment Research cut shares of Phibro Animal Health from a hold rating to a sell rating in a research report on Wednesday, August 29th. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the stock. The company currently has a consensus rating of Hold and an average target price of $43.20.
NASDAQ:PAHC opened at $42.18 on Wednesday. The company has a debt-to-equity ratio of 1.62, a current ratio of 2.90 and a quick ratio of 1.66. The company has a market cap of $1.71 billion, a P/E ratio of 24.24, a P/E/G ratio of 3.55 and a beta of 0.82. Phibro Animal Health has a fifty-two week low of $32.05 and a fifty-two week high of $54.62.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 19th. Investors of record on Wednesday, November 28th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Tuesday, November 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.14%. This is a boost from Phibro Animal Health’s previous quarterly dividend of $0.10. Phibro Animal Health’s dividend payout ratio (DPR) is presently 22.99%.
In other Phibro Animal Health news, insider Jack Bendheim sold 30,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 15th. The shares were sold at an average price of $49.75, for a total value of $1,492,500.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Daniel M. Bendheim sold 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, September 12th. The shares were sold at an average price of $44.30, for a total transaction of $110,750.00. Following the completion of the transaction, the vice president now directly owns 2,500 shares of the company’s stock, valued at approximately $110,750. The disclosure for this sale can be found here. Insiders have sold a total of 143,020 shares of company stock valued at $6,967,571 in the last ninety days. 50.29% of the stock is currently owned by corporate insiders.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
See Also: Price to Earnings Ratio (PE) Basics
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.